| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Addressing an unmet need in oncology patients: rehabilitation of upper aerodigestive tract function
|
Kupferman, M.E.
|
|
|
22 |
10 |
p. 2299-2303
|
article
|
| 2 |
A randomized phase II study of 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy compared with bevacizumab plus 5-fluorouracil, hydroxyurea, and twice-daily radiotherapy for intermediate-stage and T4N0-1 head and neck cancers
|
Salama, J.K.
|
|
|
22 |
10 |
p. 2304-2309
|
article
|
| 3 |
Choosing between the EORTC QLQ-C30 and FACT-G for measuring health-related quality of life in cancer clinical research: issues, evidence and recommendations
|
Luckett, T.
|
|
|
22 |
10 |
p. 2179-2190
|
article
|
| 4 |
Combination of hsa-miR-375 and hsa-miR-142-5p as a predictor for recurrence risk in gastric cancer patients following surgical resection
|
Zhang, X.
|
|
|
22 |
10 |
p. 2257-2266
|
article
|
| 5 |
Combining cytology, TRAP assay, and FISH analysis for the detection of bladder cancer in symptomatic patients
|
Bravaccini, S.
|
|
|
22 |
10 |
p. 2294-2298
|
article
|
| 6 |
Defining Hospital Anxiety and Depression Scale (HADS) structure by confirmatory factor analysis: a contribution to validation for oncological settings
|
Annunziata, M.A.
|
|
|
22 |
10 |
p. 2330-2333
|
article
|
| 7 |
Editorial Board
|
|
|
|
22 |
10 |
p. ii-iii
|
article
|
| 8 |
Epidermal growth factor receptor as a biomarker for cervical cancer
|
Soonthornthum, T.
|
|
|
22 |
10 |
p. 2166-2178
|
article
|
| 9 |
Grading system and management guidelines for dermatitis induced by head and neck radiotherapy plus cetuximab: clinical validation required
|
Langendijk, J.A.
|
|
|
22 |
10 |
p. 2157-2159
|
article
|
| 10 |
Health resource consumption and costs attributable to chemotherapy-induced toxicity in German routine hospital care in lymphoproliferative disorder and NSCLC patients
|
Paessens, B.J.
|
|
|
22 |
10 |
p. 2310-2319
|
article
|
| 11 |
Longitudinal changes in cardiac function after cisplatin-based chemotherapy for testicular cancer
|
Altena, R.
|
|
|
22 |
10 |
p. 2286-2293
|
article
|
| 12 |
Long-term results of International Breast Cancer Study Group Trial VIII: adjuvant chemotherapy plus goserelin compared with either therapy alone for premenopausal patients with node-negative breast cancer
|
Karlsson, P.
|
|
|
22 |
10 |
p. 2216-2226
|
article
|
| 13 |
Management of radiation dermatitis in patients receiving cetuximab and radiotherapy for locally advanced squamous cell carcinoma of the head and neck: proposals for a revised grading system and consensus management guidelines
|
Bernier, J.
|
|
|
22 |
10 |
p. 2191-2200
|
article
|
| 14 |
Outcome of advanced NSCLC patients harboring sensitizing EGFR mutations randomized to EGFR tyrosine kinase inhibitors or chemotherapy as first-line treatment: a meta-analysis
|
Bria, E.
|
|
|
22 |
10 |
p. 2277-2285
|
article
|
| 15 |
Overexpression of CXCL1 and its receptor CXCR2 promote tumor invasion in gastric cancer
|
Cheng, W.-L.
|
|
|
22 |
10 |
p. 2267-2276
|
article
|
| 16 |
Population-based survival of patients with peritoneal carcinomatosis from colorectal origin in the era of increasing use of palliative chemotherapy
|
Klaver, Y.L.B.
|
|
|
22 |
10 |
p. 2250-2256
|
article
|
| 17 |
Potential drug interactions in cancer therapy: a prevalence study using an advanced screening method
|
van Leeuwen, R.W.F.
|
|
|
22 |
10 |
p. 2334-2341
|
article
|
| 18 |
RINF (CXXC5) is overexpressed in solid tumors and is an unfavorable prognostic factor in breast cancer †
|
Knappskog, S.
|
|
|
22 |
10 |
p. 2208-2215
|
article
|
| 19 |
Sexual life of male patients with advanced renal cancer treated with angiogenesis inhibitors
|
Bessede, T.
|
|
|
22 |
10 |
p. 2320-2324
|
article
|
| 20 |
Should liver metastases of breast cancer be biopsied to improve treatment choice?
|
Curigliano, G.
|
|
|
22 |
10 |
p. 2227-2233
|
article
|
| 21 |
Src: a potential target for the treatment of triple-negative breast cancer
|
Tryfonopoulos, D.
|
|
|
22 |
10 |
p. 2234-2240
|
article
|
| 22 |
Table of Contents
|
|
|
|
22 |
10 |
p. iv-v
|
article
|
| 23 |
The unforeseen impact of meeting abstracts on cancer research
|
Krauskopf, E.
|
|
|
22 |
10 |
p. 2342
|
article
|
| 24 |
The use of Chinese herbal medicine to improve quality of life in women undergoing chemotherapy for ovarian cancer: a double-blind placebo-controlled randomized trial with immunological monitoring
|
Chan, K.K.L.
|
|
|
22 |
10 |
p. 2241-2249
|
article
|
| 25 |
Treatment of thyroid cancer with the new oral agents
|
Galofré, J.C.
|
|
|
22 |
10 |
p. 2343
|
article
|
| 26 |
Type and trends in outcomes research in breast cancer between 2000 and 2007
|
Valentini, M.
|
|
|
22 |
10 |
p. 2160-2165
|
article
|
| 27 |
What the specific tools of geriatrics and oncology can tell us about the role and status of geriatricians in a pilot geriatric oncology program
|
Sifer-Rivière, L.
|
|
|
22 |
10 |
p. 2325-2329
|
article
|
| 28 |
Which patients benefit most from adjuvant aromatase inhibitors? Results using a composite measure of prognostic risk in the BIG 1-98 randomized trial
|
Viale, G.
|
|
|
22 |
10 |
p. 2201-2207
|
article
|
Journal description